Peter A. Kiener
About
Peter A. Kiener is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Peter A. Kiener has authored 124 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 48 papers in Immunology and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter A. Kiener's work include Monoclonal and Polyclonal Antibodies Research (28 papers), Immune Cell Function and Interaction (17 papers) and T-cell and B-cell Immunology (17 papers). Peter A. Kiener is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (28 papers), Immune Cell Function and Interaction (17 papers) and T-cell and B-cell Immunology (17 papers). Peter A. Kiener collaborates with scholars based in United States, Germany and United Kingdom. Peter A. Kiener's co-authors include Herren Wu, Alejandro Aruffo, W. Conrad Liles, Bruce Rankin, Anthony J. Coyle, William F. Dall’Acqua, J A Ledbetter, S J Klebanoff, Gary C. Starling and Bahija Jallal and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Peter A. Kiener
123 papers receiving 10.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Peter A. Kiener United States | 59 | 4.4k | 3.8k | 1.7k | 1.7k | 1.6k | 124 | 10.6k | ||
| Lucien A. Aarden Netherlands | 45 | 4.4k 1.0× | 2.4k 0.6× | 1.1k 0.6× | 1.6k 1.0× | 1.2k 0.7× | 101 | 9.1k | ||
| Jean‐Yves Bonnefoy France | 54 | 6.1k 1.4× | 2.3k 0.6× | 1.3k 0.8× | 1.1k 0.7× | 1.3k 0.8× | 152 | 10.5k | ||
| Franco Dammacco Italy | 72 | 3.9k 0.9× | 5.9k 1.6× | 2.1k 1.2× | 977 0.6× | 4.3k 2.6× | 385 | 17.0k | ||
| Harvey R. Colten United States | 57 | 5.6k 1.3× | 2.6k 0.7× | 938 0.5× | 1.1k 0.6× | 912 0.6× | 231 | 11.3k | ||
| Marina Botto United Kingdom | 67 | 10.0k 2.3× | 2.9k 0.8× | 1.8k 1.1× | 1.4k 0.8× | 869 0.5× | 193 | 14.8k | ||
| Jennifer R. Gamble Australia | 64 | 4.8k 1.1× | 6.0k 1.6× | 1.1k 0.7× | 595 0.3× | 1.3k 0.8× | 157 | 14.4k | ||
| Brian L. Kotzin United States | 59 | 8.5k 1.9× | 1.7k 0.5× | 1.3k 0.8× | 2.3k 1.4× | 1.4k 0.9× | 175 | 13.5k | ||
| Thomas S. Edgington United States | 65 | 2.9k 0.6× | 4.0k 1.0× | 1.2k 0.7× | 1.2k 0.7× | 1.2k 0.7× | 204 | 14.4k | ||
| Claudia Mauri United Kingdom | 49 | 9.2k 2.1× | 2.0k 0.5× | 1.4k 0.8× | 986 0.6× | 2.0k 1.2× | 135 | 13.7k | ||
| Reinhard Voll Germany | 54 | 8.0k 1.8× | 4.5k 1.2× | 970 0.6× | 1000 0.6× | 1.6k 1.0× | 244 | 13.7k |
Countries citing papers authored by Peter A. Kiener
Since
Specialization
Citations
This map shows the geographic impact of Peter A. Kiener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Kiener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Kiener more than expected).
Fields of papers citing papers by Peter A. Kiener
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peter A. Kiener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Kiener. The network helps show where Peter A. Kiener may publish in the future.
Co-authorship network of co-authors of Peter A. Kiener
This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Kiener. A scholar is included among the top collaborators of Peter A. Kiener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Kiener. Peter A. Kiener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kearley, Jennifer, Jonas S. Erjefält, Cecilia Andersson, et al.. (2010). IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways. American Journal of Respiratory and Critical Care Medicine. 183(7). 865–875.
2.
Goutagny, Nadège, Zhaozhao Jiang, Jane Tian, et al.. (2009). Cell Type-Specific Recognition of Human Metapneumoviruses (HMPVs) by Retinoic Acid-Inducible Gene I (RIG-I) and TLR7 and Viral Interference of RIG-I Ligand Recognition by HMPV-B1 Phosphoprotein. The Journal of Immunology. 184(3). 1168–1179.
3.
Dimasi, Nazzareno, Changshou Gao, Ryan Fleming, et al.. (2009). The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators. Journal of Molecular Biology. 393(3). 672–692.
4.
Mulgrew, Kathy, David J. Stewart, Wendy L. Trigona, et al.. (2008). Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models. Cancer Research. 68. 2131–2131.
5.
Létuvé, S., Alexander Kozhich, Nassim Arouche, et al.. (2008). YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages. The Journal of Immunology. 181(7). 5167–5173.
6.
Brandl, Christian, Nadja Prang, Ralf Lutterbuese, et al.. (2008). Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells. Leukemia Research. 33(3). 465–473.
7.
Yao, Yihong, Brandon W. Higgs, Chris Morehouse, et al.. (2008). Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. PubMed. 1(1).
8.
Hammond, Scott A., Ralf Lutterbuese, Shannon Roff, et al.. (2007). Selective Targeting and Potent Control of Tumor Growth Using an EphA2/CD3-Bispecific Single-Chain Antibody Construct. Cancer Research. 67(8). 3927–3935.
9.
Wu, Herren, David S. Pfarr, Ying Tang, et al.. (2005). Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding Kinetics and Binding Valence on Viral Neutralization. Journal of Molecular Biology. 350(1). 126–144.
10.
Park, David R., Anni R. Thomsen, Charles W. Frevert, et al.. (2003). Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages. The Journal of Immunology. 170(12). 6209–6216.
11.
Salih, Helmut R. & Peter A. Kiener. (2003). Alterations in Fas (CD 95/Apo-1) and Fas Ligand (CD178) Expression in Acute Promyelocytic Leukemia during Treatment with ATRA. Leukemia & lymphoma. 45(1). 55–59.
12.
Woods, Robert M., E. Sally Ward, Susan Palaszynski, et al.. (2002). Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences. The Journal of Immunology. 169(9). 5171–5180.
13.
Diegel, Michael, Steven G. Nadler, & Peter A. Kiener. (2002). In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-κB activation. International Immunopharmacology. 2(10). 1451–1464.
14.
Salih, Helmut R., Helga Schmetzer, Christine Burke, et al.. (2001). Soluble CD137 (4-1BB) Ligand Is Released Following Leukocyte Activation and Is Found in Sera of Patients with Hematological Malignancies. The Journal of Immunology. 167(7). 4059–4066.
15.
Salih, Helmut R., Gary C. Starling, Deryk Loo, et al.. (2000). Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma Cells. The Journal of Immunology. 165(5). 2903–2910.
16.
Ledbetter, J A, J A Francisco, Clay B. Siegall, et al.. (1997). Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5.. PubMed. 17(5-6). 427–35.
17.
Starling, Gary C., Jürgen Bajorath, John Emswiler, et al.. (1997). Identification of Amino Acid Residues Important for Ligand Binding to Fas. The Journal of Experimental Medicine. 185(8). 1487–1492.
18.
Cohen, Bruce D., et al.. (1996). The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. Journal of Biological Chemistry. 271(48). 30897–30903.
19.
Liles, W. Conrad, Peter A. Kiener, J A Ledbetter, Alejandro Aruffo, & S J Klebanoff. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.. The Journal of Experimental Medicine. 184(2). 429–440.
20.
Cleaveland, Jeffrey S., Peter A. Kiener, David J. Hammond, & Bernice Schacter. (1990). A microtiter-based assay for the detection of protein tyrosine kinase activity. Analytical Biochemistry. 190(2). 249–253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lucien A. Aarden Breakdown of academic impact, for papers by Jean‐Yves Bonnefoy Breakdown of academic impact, for papers by Franco Dammacco Breakdown of academic impact, for papers by Harvey R. Colten Breakdown of academic impact, for papers by Marina Botto Breakdown of academic impact, for papers by Jennifer R. Gamble Breakdown of academic impact, for papers by Brian L. Kotzin Breakdown of academic impact, for papers by Thomas S. Edgington Breakdown of academic impact, for papers by Claudia Mauri Breakdown of academic impact, for papers by Reinhard Voll